.Pharmacolibrary.Drugs.S_SensoryOrgans.S01H_LocalAnesthetics.S01HA01_Cocaine.Cocaine .Pharmacolibrary.Drugs.S_SensoryOrgans.S01H_LocalAnesthetics.S01HA01_Cocaine.Cocaine| name: | Cocaine |
| ATC code: | S01HA01 | route: | intravenous |
| n-compartments | 2 |
Cocaine is a tropane alkaloid with local anesthetic and central nervous system stimulant properties. It blocks the reuptake of neurotransmitters such as dopamine, norepinephrine, and serotonin. In medicine, it has been used for topical anesthesia of mucous membranes, particularly in ophthalmological and otorhinolaryngological procedures. Its medical use is now highly restricted due to significant potential for abuse and toxicity.
Pharmacokinetic data from healthy adult males following intravenous administration during clinical local anesthetic procedures.
Rook, EJ, et al., & Beijnen, JH (2006). Population pharmacokinetics of heroin and its major metabolites. Clinical pharmacokinetics 45(4) 401–417. DOI:10.2165/00003088-200645040-00005 PUBMED:https://pubmed.ncbi.nlm.nih.gov/16584286
van Amsterdam, J, & van den Brink, W (2025). Explaining the high mortality among opioid-cocaine co-users compared to opioid-only users. A systematic review. Journal of addictive diseases 43(2) 121–131. DOI:10.1080/10550887.2024.2331522 PUBMED:https://pubmed.ncbi.nlm.nih.gov/38504419
Fattinger, K, et al., & Verotta, D (2000). Nasal mucosal versus gastrointestinal absorption of nasally administered cocaine. European journal of clinical pharmacology 56(4) 305–310. DOI:10.1007/s002280000147 PUBMED:https://pubmed.ncbi.nlm.nih.gov/10954344